HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yusuke Oku Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

6/2018Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ Inactivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yusuke Oku Research Topics

Disease

5Neoplasms (Cancer)
05/2021 - 04/2014
1Fibrosis (Cirrhosis)
03/2024
1Adenomatous Polyps
11/2018
1Carcinogenesis
11/2018
1Ovarian Neoplasms (Ovarian Cancer)
06/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2017
1Breast Neoplasms (Breast Cancer)
01/2017
1Lung Neoplasms (Lung Cancer)
11/2015
1Autolysis
01/2009

Drug/Important Bio-Agent (IBA)

2CateninsIBA
11/2018 - 04/2014
2Phosphotransferases (Kinase)IBA
06/2018 - 11/2015
1LuteolinIBA
03/2024
1lamellarin 14IBA
05/2021
1AzolesIBA
11/2018
1Dasatinib (BMS 354825)FDA Link
06/2018
1MLN 8237IBA
06/2018
1adavosertibIBA
06/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2018
1Proteins (Proteins, Gene)FDA Link
06/2018
1lamellarin NIBA
12/2017
1PlasticsIBA
01/2017
1Tyrosine Kinase InhibitorsIBA
11/2015
1Janus Kinase 3IBA
11/2015
1Oncogene Proteins (Oncogene Protein)IBA
01/2015
1Peptidoglycan (Murein)IBA
01/2009
1HydrolasesIBA
01/2009

Therapy/Procedure

2Therapeutics
06/2018 - 01/2015
1Drug Therapy (Chemotherapy)
06/2018
1Combination Drug Therapy (Combination Chemotherapy)
06/2018